Harvard Men's Health Watch

ED drugs after cancer treatment don't protect erectile function

Taking daily doses of the erectile dysfunction drug tadalafil (Cialis) does not reduce erectile problems in men undergoing radiation therapy for prostate cancer, according to a clinical trial in the Journal of the American Medical Association.

Some men who have radiation treatment for prostate tumors later have trouble getting or maintaining erections. Researchers have explored using ED drugs early in hopes of preventing ED after radiation or surgery for prostate cancer.

Men usually take an ED drug before initiating sexual activity. But the FDA has also approved a low-dose
version of tadalafil that is taken every day whether or not a man is planning to have sex. In this study, men were randomly assigned to take either an inactive placebo pill or a 5-milligram daily dose of tadalafil when they began radiation treatment.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »